Literature DB >> 6356515

Mycobacterial infections in marrow transplant patients.

R M Navari, K M Sullivan, S C Springmeyer, M S Siegel, J D Meyers, C D Buckner, J E Sanders, P S Stewart, R A Clift, A Fefer.   

Abstract

Bone marrow transplant recipients undergo ablation of host immune defenses with total-body irradiation or high dose chemotherapy, or both. Over a 5.6-year period, mycobacterial infections were observed in 7 of 682 patients with leukemia who received marrow grafts. Four patients had pulmonary and three extrapulmonary infection. Granulomas were observed in the lungs of three patients, in the liver of one patient, and in the skin of one patient. Cultures revealed Mycobacterium tuberculosis in two patients, Mycobacterium fortuitum in two patients, and Mycobacterium kansasii in one patient. In the six patients treated with antimycobacterial therapy in either the pretransplant or posttransplant period, complete resolution of the infection was achieved. Pretransplant chest radiograph abnormalities suggesting mycobacterial infections should be aggressively evaluated in these immunocompromised hosts. Prophylaxis should be considered in marrow graft recipients with a well-established history of inadequately treated tuberculosis, previous Bacille Calmette-Guerin immunotherapy, known family contacts, recent skin test conversion, or past skin test positivity.

Entities:  

Mesh:

Year:  1983        PMID: 6356515     DOI: 10.1097/00007890-198311000-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.

Authors:  B M Knoll
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

2.  Tuberculosis in hematopoietic stem cell transplant recipients in Korea.

Authors:  Jeeyun Lee; Mark H Lee; Won Seog Kim; Kihyun Kim; Se Hoon Park; Se-Hoon Lee; Kyung-Eun Lee; Jinny Park; Joon Oh Park; Chul Won Jung; Young-Hyuck Im; Won Ki Kang; Keunchil Park
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

Review 3.  Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.

Authors:  Nopporn Apiwattankul; Patricia M Flynn; Randall T Hayden; Elisabeth E Adderson
Journal:  J Pediatric Infect Dis Soc       Date:  2014-05-07       Impact factor: 3.164

4.  Tuberculosis before hematopoietic stem cell transplantation in patients with hematologic diseases: report of a single-center experience.

Authors:  K-S Eom; D-G Lee; H-J Lee; S-Y Cho; S-M Choi; J-K Choi; Y-J Kim; S Lee; H-J Kim; S-G Cho; J-W Lee
Journal:  Transpl Infect Dis       Date:  2015-01-12       Impact factor: 2.228

5.  Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study.

Authors:  Khalid Ahmed Al-Anazi; Asma Marzouq Al-Jasser; David Alan Price Evans
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-11-16       Impact factor: 3.944

6.  Non-tuberculous mycobacterial infection in children with cancer.

Authors:  J C Graham; D A Tweddle; D R Jenkins; C Pollitt; S J Pedler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 5.103

Review 7.  Tuberculosis in hematopoietic stem cell transplant recipients.

Authors:  Jéssica Fernandes Ramos; Marjorie Vieira Batista; Silvia Figueiredo Costa
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.